Active Biotech regains the global development and commercialization rights to Laquinimod from Teva Pharmaceutical Industries Ltd. Teva’s decision to return the rights is based on the fact that Teva does not intend to continue the clinical development of Laquinimod. As a consequence of the decision and in accordance with the license agreement, the full rights,…